Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$638,891
-22.04%
Shares
Shares Volume: 20,961 Shares
Average Share Price: $30.48
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Oct 16 2024
traded on Oct 14 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT
74,158
PURCHASES/SALES 1Y0 / 9
P/S VALUE RATION/A
AVERAGE SALE VALUE$251,617.31
INSIDER PREVIOUS TRADES
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS
with at least one purchase / sale
0 / 2
PURCHASES/SALES 1Y2 / 36
P/S VALUE RATIO0.237
AVERAGE SALE VALUE$430,910.82
COMPANY PREVIOUS TRADES
Get Feature Updates
Subscribe to our newsletter and receive the latest updates. You will get pre-access to new features